Redeye comments on Heliospectra’s rights issue, announced earlier this morning.
Långa ledtider och försiktiga investeringsbudgetar hos telekomoperatörerna, i kombination med en öka...
Jumpgate avslutar 2022 med god kostnadskontroll, stark tillväxt och en rekordstor order samt ett gen...
Redeye comments on AVTECH's latest customer addition.
The outcome of Amniotic’s rights issue was announced yesterday, March 13.
Redeye sees good prospects for continued growth as Acuvi appears to have a strong momentum with seve...
Försäljningsmässigt var år 2022 ett utmanande år för Tangiamo, där större förändringar i ledning och...
Redeye returns with a more detailed take on Integrum’s Q3 report.
Primärt effektmått uppnått i fas III Calliditas presenterade under söndagskvällen övergripande data ...
Today, 13 March 2023, the exercise period begins for the warrants of series TO 4 and TO 5 which were...
Loihde has strong long-term growth prospects and with scalability starting to kick in, we see the co...
Calliditas has presented the initial results from the Part B study featuring the 15m follow-up perio...
De första produktionslinorna är sålda och med en tillkommande kapitalinjektion samt en tidsenlig pro...
Redeye is again raising its forecasts following Systemair’s upbeat Q3 report and a positive outlook.
Positive net leasing in both Q4'22 and 2022 Finalised divestments and more to come Net LTV of 73.
ChargePanel AB (publ) meddelade den 10 mars att bolaget har ingått ett samarbete med EVPoint Ltd Mal...
Annexin Pharmaceuticals' CEO, Anders Haegerstrand, Chief Scientific and Medical Officer, Anna Froste...
Balanced mix of growth and profitability '23e-'25e EBITA CAGR of 12% Fair value range of SEK 160-220...
Gold Town Games AB (”Gold Town Games” eller ”Bolaget”) har nu fyra intäktsbringande spel lanserade g...
Redeye states that the Q4 report was very strong - from both segments but with particular emphasis o...
